ConMed Corp. (NYSE: CNMD), a surgical-device maker originally headquartered in the Utica region, recently announced some executive changes. On April 1, the company appointed Andrew Moller, 50, as principal accounting officer, according to ConMed’s Form 8-K filing with the U.S. Securities & Exchange Commission. This came after Moller had on Jan. 27 started serving in […]
ConMed Corp. (NYSE: CNMD), a surgical-device maker originally headquartered in the Utica region, recently announced some executive changes.
On April 1, the company appointed Andrew Moller, 50, as principal accounting officer, according to ConMed’s Form 8-K filing with the U.S. Securities & Exchange Commission. This came after Moller had on Jan. 27 started serving in the role of VP, corporate controller of ConMed.
The company also said Todd W. Garner, executive VP of finance and chief financial officer, has stopped serving in the role of principal accounting officer. Additionally, Kimberly A. Lockwood, who was acting as interim corporate controller, has been promoted by ConMed to senior director of financial reporting.
Moller served in a variety of positions at Smith & Nephew plc between 2019 and joining the United Kingdom–based medical-equipment manufacturer, most recently as VP, global process owner-finance and previously as chief financial officer-Asia Pacific Group. Before that, he worked in various roles at Stanley Black & Decker from 2011-2019, including director of internal audit. Moller is a certified public accountant.
ConMed is a medical technology company that provides devices and equipment for surgical procedures. The firm’s products are used by surgeons and other health-care professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
Based in Largo, Florida since 2021, ConMed still operates a facility on French Road in New Hartford, where it was formerly headquartered.
